Health

Results: 517-528 of 9493

Oncoinvent achieves 50% recruitment milestone in Phase 2 ovarian cancer study of Radspherin®

LabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibody

Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026

Tinnitus Quest Builds Momentum with Oxford Research Study, New Funding Call, and Second Tinnitus Hackathon

VahatiCor Enrolls First U.S. Patient in SERRA-I Clinical Study of A-FLUX Reducer System® for CMD

Hologic 2025 Sustainability Report

Hologic’s New Sustainability Report Marks 40 Years of Impact

Laprophan Completes the Acquisition of Rivopharm, Accelerating Its International Expansion Strategy

WCS: wise cortical strip

WISE Closes Oversubscribed Series D Financing Round of €30 Million, Welcoming ENEA Tech and Biomedical as Strategic New Investor

Almost half of Britons avoid ice cream and cold drinks due to sensitive teeth, reveals OZEN

PR Newswire associated0

FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat

The ZoyeMed 3.0 Resilience Edition - a fully standalone clinical AI terminal engineered to operate without internet connectivity, integrating point-of-care diagnostics, examination tools, and on-device AI in a single 5-square-metre footprint (Photo: AETOSWire)

Zoya Technologies Launches Clinical AI Terminal Engineered to Operate Without Internet Connectivity